Endovascular brachytherapy combined with portal vein stenting and transarterial chemoembolization improves overall survival of hepatocellular carcinoma patients with main portal vein tumor thrombus

Hepatocellular carcinoma (HCC) patients with main portal vein tumor thrombus have a median survival time of only about 4 months. We therefore compared the safety and efficacy of endovascular brachytherapy (EVBT) and sequential three-dimensional conformal radiotherapy (3-DCRT). From a cohort of 176 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Tian-Zhu, Zhang, Wen, Liu, Qing-Xin, Li, Wen-Hui, Ma, Jing-Qin, Zhang, Zi-Han, Yang, Min-Jie, Wang, Jian-Hua, Chen, Bing, Zeng, Shao-Chong, Luo, Jian-Jun, Liu, Ling-Xiao, Yan, Zhi-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355329/
https://www.ncbi.nlm.nih.gov/pubmed/28076848
http://dx.doi.org/10.18632/oncotarget.14520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355329/
https://www.ncbi.nlm.nih.gov/pubmed/28076848
http://dx.doi.org/10.18632/oncotarget.14520

Ejemplares similares